Canada Pension Plan Investment Board
AEGR

Canada Pension Plan Investment Board’s Aegerion Pharmaceuticals AEGR Stock Holding History

Canada Pension Plan Investment Board’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,100
Closed -$19K – 1216
2016
Q1 		$19K Sell
5,100
-10,600
-68% -$65.7K ﹤0.01% 1160
2015
Q4 		$159K Buy
15,700
+12,700
+423% +$153K ﹤0.01% 1028
2015
Q3 		$41K Buy
3,000
+1,400
+88% +$24.9K ﹤0.01% 1179
2015
Q2 		$30K Buy
+1,600
New +$34.6K ﹤0.01% 1219

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Canada Pension Plan Investment Board's AEGR Position: Q2 2016 in Review

Canada Pension Plan Investment Board sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2016, closing a stake of 5,100 shares — an estimated $19K sold.

Canada Pension Plan Investment Board first reported a position in AEGR in Q2 2015 and held it in 4 quarters. The position peaked at $159K in Q4 2015. 71 funds tracked by Wall St. Rank hold AEGR as of Q2 2016.

  • Canada Pension Plan Investment Board reported no remaining Aegerion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 5,100 Aegerion Pharmaceuticals shares in Q2 2016, an estimated $19K.
  • Canada Pension Plan Investment Board first reported a position in Aegerion Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Canada Pension Plan Investment Board's Aegerion Pharmaceuticals position peaked at $159K in Q4 2015.
  • 71 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2016.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2016, filed 11 Aug 2016.